Evidence map›Paper›PMID 37265097›Full record

ReviewGM crops & food2023

Sustainable access of quality seeds of genetically engineered crops in Eastern Africa - Case study of Bt Cotton.

Endale Gebre Kedisso, Joseph Guenthner, Karim Maredia, Tahani Elagib, Bernard Oloo, Samson Assefa

Abstract readReview
In one paragraph

Review in GM crops & food, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Endale Gebre KedissoDepartment of Entomology, Colleage of Agriculture and Natural Resources (CANR), Michigan State University, East Lansing, MI, USA.
Joseph GuenthnerCollege of Business and Economics, University of Idaho, Moscow, ID, USA.
Karim MarediaDepartment of Entomology, Colleage of Agriculture and Natural Resources (CANR), Michigan State University, East Lansing, MI, USA.
Tahani ElagibAgricultural Research Corporation (ARC), Khartoum, Sudan.
Bernard OlooDepartment of Dairy and Food Science and Technology, Egerton University, Nairobi, Kenya.
Samson AssefaEthiopian Textile Industry Development Institute (ETIDI), Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetically engineered bollworm-resistant Bt cotton hybrid varieties offer opportunities for reducing crop losses and enhancing productivity. In Eastern Africa region, Sudan, Ethiopia, and Kenya have approved and released Bt cotton in 2012, in 2018, and in 2019, respectively. The region has potential to grow cotton in over 5 million hectares. For commercial plantings in Ethiopia, Sudan and Kenya, hybrid Bt cotton seeds have been imported from India. Due to the COVID-19 pandemic-induced supply chain disruptions, high shipment costs, bureaucratic procedures for importing seeds, and foreign exchange shortages, farmers have not been able to access Bt cotton seeds. Stakeholders are seeking local production of seeds to provide sustainable access by farmers at affordable cost. Country case studies reveal the importance of enhancing capacity for local seed production and extension advisory services. Revival of the cotton sector needs enhanced public-private partnerships to pave the way for sustainable seeds access in the region.

Indexed as

Bacillus thuringiensisCOVID-19MothsAfrica, EasternAnimalsBacterial ProteinsCrops, AgriculturalEndotoxinsGossypiumHemolysin ProteinsHumansPandemicsPlants, Genetically ModifiedSeedsBacterial ProteinsEndotoxinsHemolysin ProteinsBiotechnologyCottonEastern AfricaEthiopiaGenetic engineeringGmosKenyaSeedsSudan

Identifiers

PMID37265097
PMCPMC10240979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.